Kiko “Kla” ta nifiká?
E animal no ta karga e mutashon. E no lo desaroyá e malesa i lo no pasa esaki.
Kachó Neuronal Ceroid Lipofuscinosis 6 Den Australian Shepherd (NCL6-AS)
Discover the importance of DNA testing for Neuronal Ceroid Lipofuscinosis 6 (NCL6) in Australian Shepherds. NCL6 is a hereditary neurological disorder that can severely impact your dog's quality of life. Early detection through a simple DNA test allows for proactive care and informed breeding decisions. By identifying carriers and affected dogs, breeders can significantly reduce the risk of this debilitating condition. Ensure your Australian Shepherd remains healthy and vibrant by prioritizing genetic testing for NCL6. Protect your furry friend and make educated choices for their future. Invest in a DNA test today to safeguard your dog's health!
Abreviashon : NCL6-AS
Mutashon analisá : CLN6 c.829T>C
Herensha : Autosomal Resesivo
Sigla
NCL6-AS
Frekuensha opservá
Severidat klíniko
Klasifikashon klíniko
Malesanan Neurológiko
Mutashon analisá
CLN6 c.829T>C
p.(W277R)
p.(W277R)
Modo di herensia
Autosomal Resesivo (Kompletu)
Resumen di prueba:
Neuronal Ceroid Lipofuscinosis 6 (NCL6) is a genetic disorder affecting Australian Shepherds, leading to progressive neurological decline. This condition is caused by mutations in the CLN6 gene, resulting in the accumulation of lipofuscin in neurons. Early symptoms often include vision problems, seizures, and behavioral changes. A DNA test is available to identify carriers and affected dogs, allowing for informed breeding decisions. Responsible testing can help reduce the incidence of NCL6 in this beloved breed.
Obtenibel for di e pakete : Basic
E tèst di DNA aki ta inkluí kuminsando for di nos pakete Basic — i tambe ta parti di e paketenan Basic, Standard, Advanced, Complete.
Wak e paketenan di tèst di DNA →Skohe e pakete ku ta pas mihó ku bo strategia di krio òf salú di bo bestianan.
Understanding Neuronal Ceroid Lipofuscinosis 6 (NCL6)
Neuronal Ceroid Lipofuscinosis 6 (NCL6) is a progressive neurodegenerative disorder that affects the central nervous system of dogs, particularly impacting the functioning of neurons. This condition is characterized by the accumulation of lipopigments, which are fatty substances that build up in the brain and other tissues. The accumulation leads to cellular dysfunction and eventually cell death, resulting in a range of neurological symptoms.
Symptoms of NCL6
The clinical signs of NCL6 often manifest in young dogs, typically between the ages of 6 months to 2 years. Common symptoms include progressive vision loss due to retinal degeneration, seizures, loss of coordination, behavioral changes, and cognitive decline. As the disease advances, affected dogs may experience difficulty with movement, muscle tremors, and an overall decline in quality of life.
Genetic Basis of NCL6
NCL6 is caused by mutations in the CLN6 gene, which plays a crucial role in cellular function, particularly in the maintenance of lysosomal function. The inheritance pattern of this condition is autosomal recessive, meaning that both copies of the mutated gene must be present for the disease to manifest. Breeding practices that identify and eliminate carriers of this mutation are essential in preventing the condition from being passed on to future generations.
Importansia di Prueba di DNA
DNA testing for NCL6 is crucial for responsible breeding practices. By identifying carriers of the CLN6 mutation, breeders can make informed decisions to avoid producing affected puppies. This proactive approach helps to manage the prevalence of NCL6 within the breed, ultimately contributing to the health and longevity of future generations of dogs.
Managing a Dog with NCL6
While there is currently no cure for NCL6, supportive care can help manage the symptoms and improve the quality of life for affected dogs. This may include a balanced diet, physical therapy, and medications to control seizures and other symptoms. Regular veterinary check-ups are essential to monitor the progression of the disease and make any necessary adjustments to the care plan.
Konklushon
Neuronal Ceroid Lipofuscinosis 6 (NCL6) is a serious genetic disorder that poses significant challenges for affected dogs and their owners. Through DNA testing and responsible breeding practices, it is possible to reduce the incidence of this condition, ensuring healthier futures for dogs at risk. Awareness, early diagnosis, and management strategies are vital for supporting dogs diagnosed with NCL6.
Rasa rekonosé pa e tèst: Neuronal Ceroid Lipofuscinosis 6 Den Australian Shepherd (NCL6-AS)
- Aussiedoodle
- Australian Shepherd
- Miniature American Shepherd
- Miniature Australian Shepherd Dog
- Toy Australian Shepherd Dog
🧬 Interpretation of genotypes NCL6-AS
Genotipo
Estado
🟡 N/N
No-transportador - Sin Riesgo
🟡 N/NCL6-AS
Transportadó - Sin Riesgo
❌ NCL6-AS/NCL6-AS
Afektá - Na Riesgo
FAQ: komprondementu di e interpretashon
Un “Transportadó” ta serio?
No. E animal ta generalmente salú pero por transmití e mutashon na su yu.
Kiko si un bestia ta “Afektá”?
E ta karga dos kopia mutá. Ta spera señalnan klíniko dependiendo di e malesa. E no mester wòrdu kriá.
Dikon tin diferensia entre hòmber/muhé?
Algun malesa ta mará na sekso, pues nan ekspreshon ta varia dependiendo di e sekso di bestia.
Pronostiká Desendiente
N/N (no-transportador) )
N/NCL6-AS (Transportador) )
NCL6-AS/NCL6-AS (Afektá) )
FAQ di Prueba di DNA
Kiko e tèst di DNA aki ta detektá?
This DNA test detects the mutation associated with Neuronal Ceroid Lipofuscinosis 6 In Australian Shepherd (NCL6) in order to identify clear, carrier, or at-risk animals.
Dikon tèst un bestia di krio?
Prueba di DNA ta yuda kriadónan plania parehamentu mas sigur i redusí e riesgo di transmití e mutashon na yunan.
Kiko ta e moda di herensia di e tèst aki?
E moda di herensia raportá pa e tèst aki ta Outosomal Resesivo.
Kua mutashon ta wòrdu analisá den e tèst aki?
This test analyses the mutation CLN6 c.829T>C.
Un bestia kargadó ta nesesariamente afektá?
No nesesariamente. Interpretashon ta dependé di e patronchi di herensia i e genotipo resultante.
Referensianan
Katz Martin L, Farias Fabiana H, Sanders Douglas N, Zeng Rong, Khan Shahnawaz, Johnson Gary S, O'Brien Dennis P. A missense mutation in canine CLN6 in an Australian shepherd with neuronal ceroid lipofuscinosis. J Biomed Biotechnol. 2011;2011:198042. doi: 10.1155/2011/198042. Epub 2010 Dec 22.